Deutsche Bank upgrades Magellan Health (Nasdaq: MGLN) to Buy from Hold. Price target increased to $46 from $36.

Deutsche analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE